273 related articles for article (PubMed ID: 25403688)
1. PTEN/PI3K/Akt/VEGF signaling and the cross talk to KRIT1, CCM2, and PDCD10 proteins in cerebral cavernous malformations.
Kar S; Samii A; Bertalanffy H
Neurosurg Rev; 2015 Apr; 38(2):229-36; discussion 236-7. PubMed ID: 25403688
[TBL] [Abstract][Full Text] [Related]
2. Role of Delta-Notch signaling in cerebral cavernous malformations.
Kar S; Baisantry A; Nabavi A; Bertalanffy H
Neurosurg Rev; 2016 Oct; 39(4):581-9. PubMed ID: 26779617
[TBL] [Abstract][Full Text] [Related]
3. Crystallographic Studies of the Cerebral Cavernous Malformations Proteins.
Fisher OS; Li X; Liu W; Zhang R; Boggon TJ
Methods Mol Biol; 2020; 2152():291-302. PubMed ID: 32524560
[TBL] [Abstract][Full Text] [Related]
4. A single-center study on 140 patients with cerebral cavernous malformations: 28 new pathogenic variants and functional characterization of a PDCD10 large deletion.
Nardella G; Visci G; Guarnieri V; Castellana S; Biagini T; Bisceglia L; Palumbo O; Trivisano M; Vaira C; Scerrati M; Debrasi D; D'Angelo V; Carella M; Merla G; Mazza T; Castori M; D'Agruma L; Fusco C
Hum Mutat; 2018 Dec; 39(12):1885-1900. PubMed ID: 30161288
[TBL] [Abstract][Full Text] [Related]
5. Cerebral cavernous malformation proteins at a glance.
Draheim KM; Fisher OS; Boggon TJ; Calderwood DA
J Cell Sci; 2014 Feb; 127(Pt 4):701-7. PubMed ID: 24481819
[TBL] [Abstract][Full Text] [Related]
6. Signaling pathways and the cerebral cavernous malformations proteins: lessons from structural biology.
Fisher OS; Boggon TJ
Cell Mol Life Sci; 2014 May; 71(10):1881-92. PubMed ID: 24287896
[TBL] [Abstract][Full Text] [Related]
7. Distinct cellular roles for PDCD10 define a gut-brain axis in cerebral cavernous malformation.
Tang AT; Sullivan KR; Hong CC; Goddard LM; Mahadevan A; Ren A; Pardo H; Peiper A; Griffin E; Tanes C; Mattei LM; Yang J; Li L; Mericko-Ishizuka P; Shen L; Hobson N; Girard R; Lightle R; Moore T; Shenkar R; Polster SP; Rödel CJ; Li N; Zhu Q; Whitehead KJ; Zheng X; Akers A; Morrison L; Kim H; Bittinger K; Lengner CJ; Schwaninger M; Velcich A; Augenlicht L; Abdelilah-Seyfried S; Min W; Marchuk DA; Awad IA; Kahn ML
Sci Transl Med; 2019 Nov; 11(520):. PubMed ID: 31776290
[TBL] [Abstract][Full Text] [Related]
8. Cerebral cavernous malformations: from CCM genes to endothelial cell homeostasis.
Fischer A; Zalvide J; Faurobert E; Albiges-Rizo C; Tournier-Lasserve E
Trends Mol Med; 2013 May; 19(5):302-8. PubMed ID: 23506982
[TBL] [Abstract][Full Text] [Related]
9. Differential angiogenesis function of CCM2 and CCM3 in cerebral cavernous malformations.
Zhu Y; Wu Q; Xu JF; Miller D; Sandalcioglu IE; Zhang JM; Sure U
Neurosurg Focus; 2010 Sep; 29(3):E1. PubMed ID: 20809750
[TBL] [Abstract][Full Text] [Related]
10. The cerebral cavernous malformations proteins.
Li X; Fisher OS; Boggon TJ
Oncotarget; 2015 Oct; 6(32):32279-80. PubMed ID: 26356566
[No Abstract] [Full Text] [Related]
11. A two-hit mechanism causes cerebral cavernous malformations: complete inactivation of CCM1, CCM2 or CCM3 in affected endothelial cells.
Pagenstecher A; Stahl S; Sure U; Felbor U
Hum Mol Genet; 2009 Mar; 18(5):911-8. PubMed ID: 19088124
[TBL] [Abstract][Full Text] [Related]
12. KRIT1 protein depletion modifies endothelial cell behavior via increased vascular endothelial growth factor (VEGF) signaling.
DiStefano PV; Kuebel JM; Sarelius IH; Glading AJ
J Biol Chem; 2014 Nov; 289(47):33054-65. PubMed ID: 25320085
[TBL] [Abstract][Full Text] [Related]
13. Cerebral cavernous malformations proteins inhibit Rho kinase to stabilize vascular integrity.
Stockton RA; Shenkar R; Awad IA; Ginsberg MH
J Exp Med; 2010 Apr; 207(4):881-96. PubMed ID: 20308363
[TBL] [Abstract][Full Text] [Related]
14. CCM3 interacts with CCM2 indicating common pathogenesis for cerebral cavernous malformations.
Voss K; Stahl S; Schleider E; Ullrich S; Nickel J; Mueller TD; Felbor U
Neurogenetics; 2007 Nov; 8(4):249-56. PubMed ID: 17657516
[TBL] [Abstract][Full Text] [Related]
15. Structural basis for the disruption of the cerebral cavernous malformations 2 (CCM2) interaction with Krev interaction trapped 1 (KRIT1) by disease-associated mutations.
Fisher OS; Liu W; Zhang R; Stiegler AL; Ghedia S; Weber JL; Boggon TJ
J Biol Chem; 2015 Jan; 290(5):2842-53. PubMed ID: 25525273
[TBL] [Abstract][Full Text] [Related]
16. Novel CCM1, CCM2, and CCM3 mutations in patients with cerebral cavernous malformations: in-frame deletion in CCM2 prevents formation of a CCM1/CCM2/CCM3 protein complex.
Stahl S; Gaetzner S; Voss K; Brackertz B; Schleider E; Sürücü O; Kunze E; Netzer C; Korenke C; Finckh U; Habek M; Poljakovic Z; Elbracht M; Rudnik-Schöneborn S; Bertalanffy H; Sure U; Felbor U
Hum Mutat; 2008 May; 29(5):709-17. PubMed ID: 18300272
[TBL] [Abstract][Full Text] [Related]
17. Proteomic identification of the cerebral cavernous malformation signaling complex.
Hilder TL; Malone MH; Bencharit S; Colicelli J; Haystead TA; Johnson GL; Wu CC
J Proteome Res; 2007 Nov; 6(11):4343-55. PubMed ID: 17900104
[TBL] [Abstract][Full Text] [Related]
18. Notch Signaling in Familial Cerebral Cavernous Malformations and Immunohistochemical Detection of Cleaved Notch1 Intracellular Domain.
Hasan SS; Fischer A
Methods Mol Biol; 2020; 2152():427-435. PubMed ID: 32524570
[TBL] [Abstract][Full Text] [Related]
19. Cerebral cavernous malformations arise independent of the heart of glass receptor.
Zheng X; Riant F; Bergametti F; Myers CD; Tang AT; Kleaveland B; Pan W; Yang J; Tournier-Lasserve E; Kahn ML
Stroke; 2014 May; 45(5):1505-1509. PubMed ID: 24643410
[TBL] [Abstract][Full Text] [Related]
20. CCM2 and CCM3 proteins contribute to vasculogenesis and angiogenesis in human placenta.
Tanriover G; Seval Y; Sati L; Gunel M; Demir N
Histol Histopathol; 2009 Oct; 24(10):1287-94. PubMed ID: 19688696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
